Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01545167 · ClinicalTrials.gov registry record

The North American Pancreatitis Study

A clinical trial of Pancreatitis, sponsored by University of Pittsburgh.

Completed
Registry status
2,980
Enrollment target
1
Study location

NCT01545167: Completed study of Pancreatitis, sponsored by University of Pittsburgh.

NCT01545167 is a study of Pancreatitis that has completed, run by University of Pittsburgh. The registered enrollment target is 2,980 participants, above the 447-participant average among 17 other Pancreatitis trials with a reported enrollment target (567% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01545167, a study of Pancreatitis, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
2,980 participants
Enrollment target
1
Study location

Study Summary

This study will investigate several genes and other factors measured in the blood that may cause recurrent acute pancreatitis and chronic pancreatitis. No treatment is offered as part of this study. Subjects have one single visit to provide a blood sample for genetic testing and to answer a questionnaire. Subjects are not given results of genetic testing. The study is currently enrolling African American subjects and controls only.

Conditions Studied

Interventions

  • GENETIC blood sampling

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 2,980 participants
Start Date 2008-09
Est. Completion 2014-06
University of Pittsburgh

1,238 total trials

What the finished NCT01545167 record still lists

NCT01545167 is an observational study that tracks outcomes without assigning an intervention. Its 2,980 participants enrollment target places it among the larger protocols in the corpus, above the 447-participant average among 17 other Pancreatitis trials with a reported enrollment target (567% higher).

The record links to 1 condition, with Pancreatitis appearing as the primary indexed condition, and to 1 intervention - of which blood sampling is the first listed.

NCT01545167 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01545167 about?

NCT01545167 is a clinical study titled "The North American Pancreatitis Study". This study will investigate several genes and other factors measured in the blood that may cause recurrent acute pancreatitis and chronic pancreatitis. No treatment is offered as part of this study. Subjects have one single visit to provide a blood sample for genetic testing and to answer a question...

What is the current status of trial NCT01545167?

This trial is currently completed. The enrollment target is 2,980 participants. The study started on 2008-09. Estimated completion is 2014-06.

What conditions does trial NCT01545167 study?

This clinical trial studies the following conditions: Pancreatitis.

What interventions are being tested in trial NCT01545167?

The interventions under investigation include: blood sampling (GENETIC).

Who is sponsoring clinical trial NCT01545167?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01545167 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pancreatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01545167's enrollment target sits among peer trials

2,980 1st of 17 higher than 17 of 17 other Pancreatitis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pancreatitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05297734 · 2,996 participants · NA

    Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • NCT03860883 · 2,998 participants · NA

    Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

  • NCT00004847 · 3,000 participants · Phase 1

    Diagnosis of Pheochromocytoma

  • NCT00478712 · 3,000 participants

    Hirschsprung Disease Genetic Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01545167, the US trial registry maintained by the National Library of Medicine. NCT01545167 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.